JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB259134

Human SLC41A3 knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

SLC41A3 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon2.

View Alternative Names

1010001P06Rik, AI480742, FLJ20473, OTTMUSP00000028993, OTTMUSP00000028994, SLC41A1 L2, SLC41A1 like 2, Solute carrier family 41, member 3

1 Images
Sanger Sequencing - Human SLC41A3 knockout HEK-293T cell lysate (AB259134)
  • Sanger seq

Unknown

Sanger Sequencing - Human SLC41A3 knockout HEK-293T cell lysate (AB259134)

Homozygous : 1 bp insertion in exon2

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon2.

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab259134-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human SLC41A3 knockout HEK293T cell lysate", "number":"AB259134-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB259134-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
SLC41A3
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

SLC41A3 also known as solute carrier family 41 member 3 functions as a magnesium transporter. This protein is part of the broader SLC41 family known for their role in magnesium homeostasis. SLC41A3 has a molecular mass of approximately 56 kDa. It is expressed in various human tissues with notable presence in the heart and skeletal muscle indicating its potential role in these areas.
Biological function summary

SLC41A3 participates in maintaining the cellular magnesium balance essential for many cellular processes such as enzyme activation and ion channel regulation. The protein acts individually; however it may interact with other magnesium transport proteins to achieve this balance. The maintenance of magnesium levels is necessary for proper cellular function and biochemical reactions.

Pathways

The SLC41A3 protein integrates into the magnesium homeostasis pathway which involves other proteins such as TRPM7 and CNNM2. Within these pathways SLC41A3 contributes to essential physiological processes including muscle contraction and neural activity. Its function is implicit in transport and regulation mechanisms that keep magnesium concentrations within healthy ranges.

Alterations in SLC41A3 activity can contribute to magnesium deficiency affecting neuromuscular and cardiovascular systems. Dysregulation may also associate with conditions like hypertension reflecting its involvement with disorders influenced by magnesium levels. Research on SLC41A3’s interaction with proteins such as TRPM6 offers insight into potential therapeutic targets for managing these disorders.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com